Marketing-authorisation holder · Canada
Biosyent Pharma Inc
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| THYCONVI20 mcg / ml · Solution | Levothyroxine | Canada | Marketed | 2026 |
| TIBELLA2.5 mg · Tablet | Tibolone | Canada | Marketed | 2020 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 2 | 2 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Sex hormones and modulators of the genital systemGenito-urinary system and sex hormones · ATC G03C
- Thyroid therapySystemic hormonal preparations · ATC H03A